In this connection, the potential function of YTHDF1 in CRC stemness is supported by its positive correlation with stemness markers CD133 and LGR5 across multiple CRC patient cohorts, as well as with LGR5 stem cell expression signatures and chemotherapy nonresponders. The gene discussed is LGR5; the disease is colorectal carcinoma.